How to Evaluate Any Peptides Company: The Master Checklist

Every company page on this site answers the same seven questions, and this page publishes them as a tool for evaluating any seller we have not profiled. (1) Identity: who legally operates the shop, since when, with what continuity? (2) Catalog: catalog peptides, research vials, kits, or mixed stock — and which sequences anchor it? (3) Documentation: lot-linked COAs published, representative-only, or absent? (4) Third-party testing: published independent results, claims without artifacts, or nothing? (5) Price position: above, at, or below the synthesis-cost floor (the floor arithmetic on cheap peptides)? (6) Community record: what pattern do public reports form, weighted for verifiability? (7) Continuity: domain age, ownership changes, predecessor relationships?

The seven are deliberately boring and fully public. Boring is the feature: the checklist converts the unanswerable question ("is this company good?") into seven checkable ones, each answerable from a browser in minutes. A seller that fails questions 3 and 4 fails the market's only meaningful quality axis, whatever its review scores say.

The questions are not equally weighted. Documentation (3) and identity verification (4) dominate: they are the only signals that are both meaningful and hard to fake at scale. Price position (5) is a plausibility screen rather than a quality measure. Community record (6) is a weak prior — the weighting we demonstrate on the Peptide Sciences Reddit case. Continuity (7) sets the base rate: new domains selling mature catalogs get more scrutiny, deservedly, given the exit-and-rename pattern documented across our gray market structure page.

Applied across the market, the checklist is what generates our tier map on the top peptide companies pillar: CDMOs and catalog houses pass on documents by default; research-vial shops distribute across the whole range; and each individual profile — from Polaris Peptides to Peptyx Labs — is the checklist applied to one public footprint. Corrections and updates are welcome via contact; the editorial policy governs how we handle them.

Step 1 — run the seven questions. For any question raised about How to Evaluate Any Peptides Company, write one line per dimension in the table above: identity, catalog, documentation, third-party testing, price position, community record, continuity. Empty lines are findings, not failures of research — they describe exactly what the public record lacks. Step 2 — weight by evidence class. Registry records and dated documents outrank community threads; community threads outrank undated sentiment; successor claims are not evidence at all. A profile is strong when most dimensions rest on the first two classes. Step 3 — date every conclusion. This market churns: domains change hands, documentation habits drift, and a profile accurate this quarter may not be accurate in the next. Record when you checked, and re-run the checklist on ownership signals. The method itself is documented in the top peptide companies pillar; Anavar Reddit shows the same checklist applied to a different company.

Every company profile on this site is built from the same seven dimensions. Use this table to score any peptide company — profiled here or not — before treating any single reputation claim as evidence.

Table: Parameter comparison: the seven company-evaluation dimensions — apply it to any page in this cluster.